Journal of Cardiothoracic Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2023-07-06 ms3000001669440456 来自广东省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：心胸外科
经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投

108 0

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2022-09-29 1463b3a1m11暂无昵称

完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼)

116 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2022-12-26 mymartin123

审稿速度:12.0
经验分享：慎投

112 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2022-11-07 121a1d77m08暂无昵称

请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？

111 0

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2022-07-18 ms6000000719507605

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：心血管
经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2022-10-25 1463b3a1m11暂无昵称

偏重的研究方向：心血管
经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了

110 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2021-10-06 14878573m53(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0
偏重的研究方向：胸心外科
经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。

163 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2022-04-24 ms6000000719507605

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：心血管
经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思

118 0

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2022-04-18 ms6000001123875783

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：论著
经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。

141 0

[GetPortalCommentsPageByObjectIdResponse(id=2146601, encodeId=9c4721466012b, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：心胸外科 经验分享：11月下旬提交手稿，4月中旬返修，6月底接收，前后接近7个多月，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef665580734, createdName=ms3000001669440456, createdTime=Thu Jul 06 10:31:36 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0 经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098897, encodeId=5ceb209889e5a, content=请问这个杂志是不是从爱思唯尔改到Springer nature出版社了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7jO7nKYbNkiclTMLIA3XMVkVmbd3xBN11FwqrOFu8HPf38XMSBoBQmZCocQovMiaq88s3uW2TiaaAg/132, createdBy=38122270090, createdName=121a1d77m08暂无昵称, createdTime=Mon Nov 07 00:34:07 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管 经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0 偏重的研究方向：胸心外科 经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213847, encodeId=d150121384e09, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：心血管 经验分享：2月份投的article，4月中给了一个审稿人的意见，major revision。JCTS的审稿人意见是一个个回来的吗？看邮件怎么是只有一个的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Sun Apr 24 10:06:25 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212174, encodeId=205912121e40e, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：论著 经验分享：2021年7月投出，一审时间巨长，中间催两次稿，2022年2月回一审稿人意见，小修一周后返回，再次送审，1月后回另一审稿人意见，同意接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e955415218, createdName=ms6000001123875783, createdTime=Mon Apr 18 13:55:50 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=)]

2021-01-21 1551f63e90m

Reviews Completed 要多长时间，已经一个月了

184 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务